These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1394244)

  • 1. Hypotensive and bradycardiac responses to thyrotropin-releasing hormone in a comatose patient.
    Aibiki M; Shirakawa Y; Komatsu H; Yamaguchi Y; Ogura S; Ogli K
    Clin Neuropharmacol; 1992 Jun; 15(3):236-40. PubMed ID: 1394244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin-releasing hormone produces different hemodynamic effects in vegetative and brain-dead patients.
    Aibiki M; Shirakawa Y; Ogura S; Uefuji T; Seki K; Umegaki O; Ogli K
    Clin Neuropharmacol; 1993 Oct; 16(5):428-37. PubMed ID: 8221703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin-releasing hormone reverses the hypotension and bradycardia produced by leukotriene D4 in unanesthetized guinea pigs.
    Lux WE; Feuerstein G; Faden AI
    Prostaglandins Leukot Med; 1983 Mar; 10(3):301-7. PubMed ID: 6405395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypotensive and bradycardiac responses to reflex sympathetic inhibition produced by nitroglycerin in rats with sinoaortic deafferentation.
    Ma S; Long JP
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):136-43. PubMed ID: 7678669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of thyrotropin releasing hormone as a therapeutic intervention for endotoxemia.
    Brackett DJ; Schaefer CF; Lerner MR; Holaday JW; Fagraeus L; Wilson MF
    Regul Pept; 1990 Jul; 29(2-3):153-62. PubMed ID: 2120745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of thyrotropin-releasing hormone in normotensive and hypotensive rats: role of rostral ventrolateral medulla.
    Yan J; Chen H; Liao W; Lu S
    Circ Shock; 1992 Jul; 37(3):253-61. PubMed ID: 1423917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene D4-induced hypotension is reversed by thyrotropin-releasing hormone.
    Feuerstein G; Zukowska-Grojec Z; Bayorh M; Kopin IJ; Faden AI
    Prostaglandins; 1983 Nov; 26(5):711-24. PubMed ID: 6422508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathomimetic pressor responses to thyrotropin-releasing hormone in rats.
    Mattila J; Buñag RD
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H86-92. PubMed ID: 3089031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Nitro-2-phenylethane, the main constituent of the essential oil of Aniba canelilla, elicits a vago-vagal bradycardiac and depressor reflex in normotensive rats.
    de Siqueira RJ; Macedo FI; Interaminense Lde F; Duarte GP; Magalhães PJ; Brito TS; da Silva JK; Maia JG; Sousa PJ; Leal-Cardoso JH; Lahlou S
    Eur J Pharmacol; 2010 Jul; 638(1-3):90-8. PubMed ID: 20406629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone.
    Feuerstein G; Lux WE; Snyder F; Ezra D; Faden AI
    Circ Shock; 1984; 13(3):255-60. PubMed ID: 6432359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of captopril on the baroreflex of normotensive and spontaneously hypertensive rats.
    Takeda K; Ashizawa H; Oguro M; Nakamura Y; Fukuyama M; Lee LC; Inoue A; Sasaki S; Yoshimura M; Nakagawa M
    Jpn Heart J; 1986 Jul; 27(4):511-21. PubMed ID: 3537354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intracerebroventricular administration of thyrotrophic-releasing hormone on cardiovascular function in the rat.
    Tsay BL; Lin MT
    Neuroendocrinology; 1982; 35(3):173-7. PubMed ID: 6813757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The involvement of central cholinergic mechanisms in cardiovascular responses to intracerebroventricular and intravenous administration of thyrotropin-releasing hormone.
    Okuda C; Mizobe T; Miyazaki M
    Life Sci; 1987 Mar; 40(13):1293-9. PubMed ID: 3104710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambient temperature modulates the differentiated cardiorespiratory pattern generated by the central noradrenergic system, most likely via alterations of thyrotropin-releasing hormone (TRH) activity.
    Riedel W
    J Auton Nerv Syst; 1985; 12(2-3):145-57. PubMed ID: 3923090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic vasoconstriction and renin secretion cause pressor responses to thyrotropin-releasing hormone in rats.
    Mattila J; Buñag RD
    J Pharmacol Exp Ther; 1986 Jul; 238(1):232-6. PubMed ID: 3088259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenals.
    Helke CJ; Phillips ET
    J Pharmacol Exp Ther; 1988 Apr; 245(1):41-6. PubMed ID: 2834544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin-releasing hormone given intrathecally to the rat increases arterial pressure and heart rate.
    Yashpal K; Gauthier S; Henry JL
    Circ Res; 1989 Oct; 65(4):859-68. PubMed ID: 2551531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenyldiguanide activates cardiac receptors to produce responses by involving three different efferent pathways in anaesthetized rats.
    Bagchi S; Deshpande SB
    Indian J Exp Biol; 2000 Sep; 38(9):881-6. PubMed ID: 12561945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin-releasing hormone (TRH) causes sympathetic activation and cerebral vasodilation in the rabbit.
    Koskinen LO; Bill A
    Acta Physiol Scand; 1984 Oct; 122(2):127-36. PubMed ID: 6097095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of regional cerebral blood flow to thyrotropin-releasing hormone therapy in acute encephalitis and encephalopathy during childhood.
    Yoshinari S; Hamano S; Tanaka M; Minamitani M
    Eur J Paediatr Neurol; 2006 May; 10(3):124-8. PubMed ID: 16757195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.